AGX814

SARS-Cov-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 616

suitable for ELISA

• Synonim(y): 2019-nCoV, COVID-19
• Kod UNSPSC: 51201600

Właściwości

• rekombinowane: expressed in E. coli
• Poziom jakości: 100
• Postać: liquid
• masa cząsteczkowa: ≤72 kDa
• warunki przechowywania: avoid repeated freeze/thaw cycles
• metody: ELISA: suitable
• Warunki transportu: dry ice

Opis

Opis ogólny

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, expressed in E. coli, Cat. No. AGX814 is for use in ELISA.

Opis wartości docelowych

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Postać fizyczna

Purified protein in 25mM Tris-HCl without preservatives, pH 8.0.

Rekonstytucja

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Przechowywanie i stabilność

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Oświadczenie o zrzeczeniu się odpowiedzialności

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 12 - Non Combustible Liquids
• Klasa zagrożenia wodnego (WGK): nwg
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable